NFKB1 and inflammatory bowel disease: This could be explained by the mechanism described by Curtis et al. [16] that suggest an inflammatory response in diseases such as IBD is regulated by transcription factors (e.g., NF-κB and HIF) that are posttranslationally modified to control the kinetics of their expression, primarily through proteasomal degradation pathways [15, 16].